The potential utility of melatonin in the treatment of childhood cancer.
Study Goal
The researchers aimed to evaluate melatonin's potential as a therapeutic agent for treating childhood cancer, focusing on its safety and efficacy.
Results Summary
Melatonin demonstrated significant positive effects on adult cancers, improving survival and treatment response rates while slowing disease progression, and appears safe for children.
Population
Children with cancer (potential application based on adult studies).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
melatonin | increase | survival rates | adults with cancer | - | has significant positive effects | #1 |
melatonin | increase | treatment response rates | adults with cancer | - | has significant positive effects | #2 |
melatonin | decrease | disease progression | adults with cancer | - | slowing | #3 |
melatonin | no change | - | children | - | appears to be safe | #4 |
Childhood cancer management has improved considerably, with the overall objective of preventing early-life cancers completely. However, cancer remains a major cause of death in children, with the survivors developing anticancer treatment-specific health problems. Therefore, the anticancer treatment needs further improvement. Melatonin is a effective antioxidant and circadian pacemaker. Through multiple mechanisms, melatonin has significant positive effects on multitude adult cancers by increasing survival and treatment response rates, and slowing disease progression. In addition, melatonin appears to be safe for children. As an appealing therapeutic agent, we herein address several key concerns regarding melatonin's potential for treating children with cancer.